The purpose of the Bioinformatics Core is to develop, validate, and use several established bioinformatics tools for the study of protective mechanisms against pandemic respiratory virus. The informatics platforms developed through the Bioinformatics Core will be used to study samples provided by Projects 1-3. Datasets, protocols, reagent lists, and informatics tools will be placed on a website that will be developed as part of this proposal. The goals of the Bioinformatics Core will be (1) to connect with all the various Projects that are generating primary data, (2) to acquire all the relevant data and store it in open formats, (3) to collaborate with the other NIH-funded Cooperative Centers for Translational Research on Human Immunology and Biodefense and share data in a bi-directional manner, (4) to serve data to the Projects for hypothesis testing, (5) to publish the data for public availability, and (6) to provide robust statistical and analytical methods to analyze the data. The highest priority for the Bioinformatics Core is to directly work with all Projects to address their need for robust statistical techniques. In addition to analytic support, the Bioinformatics Core will operationalize collaboration, data-, and method-sharing with other NIH-funded Cooperative Centers for Translational Research on Human Immunology and Biodefense. Finally, the Bioinformatics Core will work with all Projects to publish data to the Internet. To achieve these goals, the Bioinformatics Core will create a software infrastructure to enable state-of-the-art distribution, storage and analysis of multiple types of genome-scale data. This will enable researchers from all Cooperative Centers to maximally utilize the genomic, proteomic, immunogenomic, and phenotypic data sets to determine functional dependencies among the measured elements and direct further biological validation of these putative dependencies.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program--Cooperative Agreements (U19)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-KS-I)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Stanford University
United States
Zip Code
Haynes, Winston A; Vallania, Francesco; Liu, Charles et al. (2016) EMPOWERING MULTI-COHORT GENE EXPRESSION ANALYSIS TO INCREASE REPRODUCIBILITY. Pac Symp Biocomput 22:144-153
Fragiadakis, Gabriela K; Baca, Quentin J; Gherardini, Pier Federico et al. (2016) Mapping the Fetomaternal Peripheral Immune System at Term Pregnancy. J Immunol 197:4482-4492
Sharon, Eilon; Sibener, Leah V; Battle, Alexis et al. (2016) Genetic variation in MHC proteins is associated with T cell receptor expression biases. Nat Genet 48:995-1002
Adams, Jarrett J; Narayanan, Samanthi; Birnbaum, Michael E et al. (2016) Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity. Nat Immunol 17:87-94
Rubelt, Florian; Bolen, Christopher R; McGuire, Helen M et al. (2016) Individual heritable differences result in unique cell lymphocyte receptor repertoires of naïve and antigen-experienced cells. Nat Commun 7:11112
Angst, Martin S; Fragiadakis, Gabriela K; Gaudillière, Brice et al. (2016) In Reply. Anesthesiology 124:1414-5
Holmes, Tyson H; He, Xiao-Song (2016) Human immunophenotyping via low-variance, low-bias, interpretive regression modeling of small, wide data sets: Application to aging and immune response to influenza vaccination. J Immunol Methods 437:1-12
Frei, Andreas P; Bava, Felice-Alessio; Zunder, Eli R et al. (2016) Highly multiplexed simultaneous detection of RNAs and proteins in single cells. Nat Methods 13:269-75
Sweeney, Timothy E; Braviak, Lindsay; Tato, Cristina M et al. (2016) Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis. Lancet Respir Med 4:213-24
Kovats, S; Turner, S; Simmons, A et al. (2016) West Nile virus-infected human dendritic cells fail to fully activate invariant natural killer T cells. Clin Exp Immunol 186:214-226

Showing the most recent 10 out of 158 publications